Articles related to Cardiology

In a single-center cross-sectional study of 75 symptomatic patients, coronary artery calcium score and carotid intima-media thickness were associated with CT-derived CAD severity. The findings support risk-stratification interest but require prospective validation.

The FDA approved Furoscix ReadyFlow, a subcutaneous furosemide autoinjector for edema associated with heart failure or chronic kidney disease. Clinical data demonstrated pharmacokinetic exposure and diuretic effects comparable to intravenous furosemide.

The ACC updated its expert consensus pathway for HFpEF, emphasizing diagnostic scoring, comorbidity assessment, and newer cardiometabolic therapies. The pathway reflects emerging evidence while remaining aligned with existing heart failure guidelines.

Women presenting with acute myocardial infarction often report chest pain alongside additional symptoms such as dyspnea, nausea, fatigue, or jaw pain. Persistent diagnostic disparities continue to contribute to delays in recognition and treatment, particularly among younger women.

The 2026 ACC/AHA dyslipidemia guideline reintroduces LDL-C treatment targets, expands risk assessment, and recommends universal Lp(a) screening. New analyses suggest many US adults now exceed recommended cholesterol thresholds, although treatment decisions remain individualized.

A post-thyroidectomy patient’s LDL-C rose above 250 mg/dL during recurrent hypothyroidism and improved after euthyroidism returned. The case highlights medication adherence and secondary-cause review before lipid-therapy escalation.